Diseases, Conditions, Syndromes

Immunosuppressant response predicts aplastic anemia survival

(HealthDay)—Response to immunosuppressive therapy (IST) predicts overall survival (OS) in aplastic anemia (AA), according to a study published online Aug. 29 in the American Journal of Hematology.

Oncology & Cancer

What makes some cancers more deadly?

A Flinders University researcher is searching for answers as to why some leukaemia sufferers live a normal lifespan while others succumb to the disease within months.

Oncology & Cancer

CYP3A7*1C allele linked to cancer mortality, progression

(HealthDay)—The CYP3A7*1C allele appears to be associated with mortality and disease progression in specific cancers, according to a study published online March 10 in Cancer Research.

Immunology

Lipid helps lymphocytes patrol

The mechanism of efficient lymphocyte motility within lymphoid tissues has remained unknown. A research group led by Osaka University and the University of Turku has found for the first time that a lipid called lysophosphatidic ...

Oncology & Cancer

New treatment target identified for aggressive lymphomas

Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have identified a possible therapeutic target for two types of very aggressive lymphomas. The CNIC team discovered that the microRNA ...

Medications

Zydelig approved for three types of blood cancer

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

page 40 from 40